Gilteritinib
- $32 - $1000
- Product name: Gilteritinib
- CAS: 1254053-43-4
- MF: C29H44N8O3
- MW: 552.71
- EINECS:
- MDL Number:MFCD28144685
- Synonyms:ASP-2215;2-Pyrazinecarboxamide, 6-ethyl-3-[[3-methoxy-4-[4-(4-methyl-1-piperazinyl)-1-piperidinyl]phenyl]amino]-5-[(tetrahydro-2H-pyran-4-yl)amino]-;6-Ethyl-3-[[3-methoxy-4-[4-(4-methyl-1-piperazinyl)-1-piperidinyl]phenyl]amino]-5-[(tetrahydro-2H-pyran-4-yl)amino]-2-pyrazinecarboxamide;6-ethyl-3-((3-methoxy-4-(4-(4-methylpiperazin-1-yl)piperidin-1-yl)phenyl)amino)-5-((tetrahydro-2H-pyran-4-yl)amino)pyrazine-2-carboxamide;Gilteritinib (ASP2215);6-Ethyl-3-((3-methoxy-4-(4-(4-methylpiperazin-1-yl)piperidin-1-yl)phenyl)-amino)-5-((tetrahydr;ASP2215(Gilteritinib);Gilteritinib(free base)
17 prices
Selected condition:
Brand
- Biosynth Carbosynth
- Cayman Chemical
- ChemScene
- DC Chemicals
- TRC
- Usbiological
Package
- 1mg
- 5mg
- 10mg
- 25mg
- 50mg
- 100mg
- 250mg
- ManufacturerBiosynth Carbosynth
- Product numberBG166434
- Product descriptionGilteritinib
- Packaging10mg
- Price$145
- Updated2021-12-16
- Buy
- ManufacturerBiosynth Carbosynth
- Product numberBG166434
- Product descriptionGilteritinib
- Packaging25mg
- Price$250
- Updated2021-12-16
- Buy
- ManufacturerBiosynth Carbosynth
- Product numberBG166434
- Product descriptionGilteritinib
- Packaging50mg
- Price$345
- Updated2021-12-16
- Buy
- ManufacturerBiosynth Carbosynth
- Product numberBG166434
- Product descriptionGilteritinib
- Packaging100mg
- Price$540
- Updated2021-12-16
- Buy
- ManufacturerBiosynth Carbosynth
- Product numberBG166434
- Product descriptionGilteritinib
- Packaging250mg
- Price$1000
- Updated2021-12-16
- Buy
- ManufacturerCayman Chemical
- Product number21503
- Product descriptionGilteritinib ≥98%
- Packaging1mg
- Price$32
- Updated2024-03-01
- Buy
- ManufacturerCayman Chemical
- Product number21503
- Product descriptionGilteritinib ≥98%
- Packaging5mg
- Price$116
- Updated2024-03-01
- Buy
- ManufacturerCayman Chemical
- Product number21503
- Product descriptionGilteritinib ≥98%
- Packaging10mg
- Price$214
- Updated2024-03-01
- Buy
- ManufacturerCayman Chemical
- Product number21503
- Product descriptionGilteritinib ≥98%
- Packaging25mg
- Price$381
- Updated2024-03-01
- Buy
- ManufacturerChemScene
- Product numberCS-3885
- Product descriptionGilteritinib 99.55%
- Packaging5mg
- Price$100
- Updated2021-12-16
- Buy
- ManufacturerChemScene
- Product numberCS-3885
- Product descriptionGilteritinib 99.55%
- Packaging10mg
- Price$150
- Updated2021-12-16
- Buy
- ManufacturerChemScene
- Product numberCS-3885
- Product descriptionGilteritinib 99.55%
- Packaging50mg
- Price$350
- Updated2021-12-16
- Buy
- ManufacturerChemScene
- Product numberCS-3885
- Product descriptionGilteritinib 99.55%
- Packaging100mg
- Price$550
- Updated2021-12-16
- Buy
- ManufacturerDC Chemicals
- Product numberDC8164
- Product descriptionGilteritinib(ASP2215) >98%
- Packaging100mg
- Price$450
- Updated2021-12-16
- Buy
- ManufacturerDC Chemicals
- Product numberDC8164
- Product descriptionGilteritinib(ASP2215) >98%
- Packaging250mg
- Price$750
- Updated2021-12-16
- Buy
- ManufacturerTRC
- Product numberG377700
- Product descriptionGilteritinib
- Packaging100mg
- Price$945
- Updated2021-12-16
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
Biosynth Carbosynth | BG166434 | Gilteritinib | 10mg | $145 | 2021-12-16 | Buy |
Biosynth Carbosynth | BG166434 | Gilteritinib | 25mg | $250 | 2021-12-16 | Buy |
Biosynth Carbosynth | BG166434 | Gilteritinib | 50mg | $345 | 2021-12-16 | Buy |
Biosynth Carbosynth | BG166434 | Gilteritinib | 100mg | $540 | 2021-12-16 | Buy |
Biosynth Carbosynth | BG166434 | Gilteritinib | 250mg | $1000 | 2021-12-16 | Buy |
Cayman Chemical | 21503 | Gilteritinib ≥98% | 1mg | $32 | 2024-03-01 | Buy |
Cayman Chemical | 21503 | Gilteritinib ≥98% | 5mg | $116 | 2024-03-01 | Buy |
Cayman Chemical | 21503 | Gilteritinib ≥98% | 10mg | $214 | 2024-03-01 | Buy |
Cayman Chemical | 21503 | Gilteritinib ≥98% | 25mg | $381 | 2024-03-01 | Buy |
ChemScene | CS-3885 | Gilteritinib 99.55% | 5mg | $100 | 2021-12-16 | Buy |
ChemScene | CS-3885 | Gilteritinib 99.55% | 10mg | $150 | 2021-12-16 | Buy |
ChemScene | CS-3885 | Gilteritinib 99.55% | 50mg | $350 | 2021-12-16 | Buy |
ChemScene | CS-3885 | Gilteritinib 99.55% | 100mg | $550 | 2021-12-16 | Buy |
DC Chemicals | DC8164 | Gilteritinib(ASP2215) >98% | 100mg | $450 | 2021-12-16 | Buy |
DC Chemicals | DC8164 | Gilteritinib(ASP2215) >98% | 250mg | $750 | 2021-12-16 | Buy |
TRC | G377700 | Gilteritinib | 100mg | $945 | 2021-12-16 | Buy |
Properties
Melting point :>157°C (dec.)
Boiling point :696.9±55.0 °C(Predicted)
Density :1.242±0.06 g/cm3(Predicted)
storage temp. :-20°C
solubility :Soluble in DMSO (25 mg/ml)
form :solid
pka :14.39±0.50(Predicted)
color :Off-white to pale pink
Stability :Stable for 1 year as supplied. Solutions in DMSO may be stored at -20°C for up to 3 months.
Boiling point :696.9±55.0 °C(Predicted)
Density :1.242±0.06 g/cm3(Predicted)
storage temp. :-20°C
solubility :Soluble in DMSO (25 mg/ml)
form :solid
pka :14.39±0.50(Predicted)
color :Off-white to pale pink
Stability :Stable for 1 year as supplied. Solutions in DMSO may be stored at -20°C for up to 3 months.
Safety Information
Symbol(GHS): | |||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Signal word: | Warning | ||||||||||||||||||||||||||||||
Hazard statements: |
|
||||||||||||||||||||||||||||||
Precautionary statements: |
|
Description
Gilteritinib is an inhibitor of FMS-related tyrosine kinase 3 (FLT3; IC50 = 5 nM for the wild-type enzyme). It inhibits mutant forms of FLT3, including FLT3 with the internal tandem duplication mutation (FLT3-ITD), FLT3-ITD expressing the F691L mutation, and FLT3 with various tyrosine kinase domain mutations (FLT3-TKD; IC50s =1.4-1.8, 12.2, and 0.7-2 nM, respectively). Gilteritinib also inhibits Axl and c-Kit with IC50 values of 41 and 102 nM, respectively. It decreases the viability of blast cells isolated from patients with relapsed acute myeloid leukemia (AML) in a concentration-dependent manner. Formulations containing gilteritinib have been used in the treatment of AML.Related product price
- 1097917-15-1
$39-12210 - ABX-1431
$22-2839 - 936091-14-4
$44-4042.5
Suppliers and manufacturers
Hangzhou FandaChem Co.,Ltd.
ATK CHEMICAL COMPANY LIMITED
BOC Sciences
Xi'an Yutbon Pharmaceutical Technology Co., Ltd
HANGZHOU CLAP TECHNOLOGY CO.,LTD
ANHUI WITOP BIOTECH CO., LTD